Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “STGD1”

67 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 67 results

Testing effectiveness (Phase 2)Study completedNCT01469832
What this trial is testing

Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)

Who this might be right for
Stargardt's Macular Dystrophy
Astellas Institute for Regenerative Medicine 12
Testing effectiveness (Phase 2)Study completedNCT03364153
What this trial is testing

Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)

Who this might be right for
Stargardt's Macular Dystrophy
Astellas Pharma Global Development, Inc. 121
Early research (Phase 1)Looking for participantsNCT07836452
What this trial is testing

A Phase 1, First-in-Human Study of CITY-RBP4 in Healthy Volunteers and STGD1 Participants

Who this might be right for
Stargardt Disease 1STGD1Healthy Volunteers
City Therapeutics 48
Very early researchLooking for participantsNCT07063251
What this trial is testing

An Clinical Study Evaluating the Safety, Tolerability, and efficAcy of HG005 in StaRgardT Disease

Who this might be right for
Stargardt Disease Type 1 (STGD1)
HuidaGene Therapeutics Co., Ltd. 6
Early research (Phase 1)Looking for participantsNCT07594236
What this trial is testing

Phase 1 Study of C.001 in Retinal Degeneration

Who this might be right for
Geographic AtrophyStargardt DiseaseRPE-mediated Maculopathy+1 more
Cellio Therapeutics Inc 15
Not applicableEnded earlyNCT01676766
What this trial is testing

Novel Quantification Methods for Fluorescence to Detect Progression in Stargardt Disease

Who this might be right for
Stargardt Disease
University of Michigan 2
Not applicableLooking for participantsNCT07266584
What this trial is testing

Restoration of Central Vision With PRIMA in Patients With Photoreceptor Degeneration

Who this might be right for
Stargardt DiseaseRetinitis Pigmentosa (RP)Inherited Retinal Degeneration
Science Corporation 5
Not applicableNot Yet RecruitingNCT07265895
What this trial is testing

Inherited Retinal Diseases: Natural History and Genotype-Phenotype Correlations

Who this might be right for
Retinal DegenerationsRetinitis Pigmentosa (RP)Stargardt Disease
IRCCS San Raffaele 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT02402660
What this trial is testing

Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease

Who this might be right for
Stargardt DiseaseStargardt Macular DegenerationStargardt Macular Dystrophy+1 more
Alkeus Pharmaceuticals, Inc. 160
Not applicableLooking for participantsNCT06445322
What this trial is testing

Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)

Who this might be right for
Stargardt DiseaseStargardt Disease 1Cone Rod Dystrophy+1 more
Ascidian Therapeutics, Inc 50
Not applicableEnded earlyNCT02875704
What this trial is testing

Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy

Who this might be right for
Stargardt DiseaseDiabetic RetinopathyMacular Degeneration (Age Related)
Johns Hopkins University 77
Large-scale testing (Phase 3)Study completedNCT03772665
What this trial is testing

Safety and Efficacy of Emixustat in Stargardt Disease

Who this might be right for
Stargardt Disease
Kubota Vision Inc. 194
Not applicableStudy completedNCT04909398
What this trial is testing

Pupil Dynamics and Color Vision for the Detection of Eye Diseases

Who this might be right for
Retinitis PigmentosaLeber's Hereditary Optic NeuropathyStargardt Disease
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 60
Testing effectiveness (Phase 2)Study completedNCT02903576
What this trial is testing

Stem Cell Therapy for Outer Retinal Degenerations

Who this might be right for
Age Related Macular DegenerationStargardt's DiseaseExudative Age-related Macular Degeneration
Federal University of São Paulo 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT04545736
What this trial is testing

Oral Metformin for Treatment of ABCA4 Retinopathy

Who this might be right for
ABCA4 RetinopathyStargardt DiseaseRetinal Dystrophy+1 more
National Eye Institute (NEI) 55
Testing effectiveness (Phase 2)Study completedNCT04489511
What this trial is testing

Study of STG-001 in Subjects With Stargardt Disease

Who this might be right for
Stargardt Disease-1
Stargazer Pharmaceuticals, Inc. 10
Early research (Phase 1)Study completedNCT00060749
What this trial is testing

Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-like Macular Dystrophy

Who this might be right for
Macular Degeneration
National Eye Institute (NEI) 22
Not applicableStudy completedNCT06377150
What this trial is testing

ABCA4-associated Disease in Childhood and Adolescence - a Phenotype Study

Who this might be right for
Stargardt Disease
University Hospital Tuebingen 39
Not applicableStudy completedNCT02941991
What this trial is testing

A Follow up Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)

Who this might be right for
Stargardt's Macular Dystrophy
Astellas Institute for Regenerative Medicine 12
Testing effectiveness (Phase 2)Study completedNCT05417126
What this trial is testing

Safety and Effects of a Single Intravitreal Injection of vMCO-010 Optogenetic Therapy in Subjects With Stargardt Disease

Who this might be right for
Stargardt Disease
Nanoscope Therapeutics Inc. 6
Next Page